The Gross Margin of Nektar Therapeutics (NKTR) is 68.82%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 68.82% |
| 2023-12-31 | 62.53% |
| 2022-12-31 | 76.44% |
| 2021-12-31 | 75.56% |
| 2020-12-31 | 87.25% |
| 2019-12-31 | 81.33% |
| 2018-12-31 | 97.96% |
| 2017-12-31 | 90.09% |
| 2016-12-31 | 81.74% |
| 2015-12-31 | 85.23% |